Forecast & Rating14 analysts currently cover SINOPHARM, with about 71.4% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$22.80, about 36.9% upside from the current price of HK$16.65. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 29.6% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study SINOPHARM closely still see room for the stock to rise. Data as of Aug 7, 2026; for reference only and not investment advice.
Aug 6, 2026Price forecast
HK$22.8036.94%
Forecast & RatingBuy
14analysts
- Strong buy50.00%
- Buy21.43%
- Hold28.57%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met21.9%
Stock price$16.65
Avg. target$22.5
High target$25
Low target$19
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.